| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Novocure Limited (NVCR) has 8 insiders with recent SEC Form 4 filings, including 0 buys and 17 sells. NVCR is classified in the Health Care Equipment & Supplies industry within the Health Care sector.
| Role | Insider | Shares | Value | 30d |
|---|---|---|---|---|
| CEO | 437.6K | $6.59M | - | |
| Dir | 416.5K | $6.27M | - | |
| VP | 347.7K | $5.23M | - | |
| Other | 174.5K | $2.63M | - | |
| Other | 163.8K | $2.46M | - |
Buys and sells only
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|
| Jun 26, 2017 | Pomona Capital Vii, L.P. | 10% Owner | Sell | 1,072,532 | $17.35 | $18,607,079.50 | -5.7% | |
| Jun 21, 2017 | Kirson Eilon D. | Chief Science Officer | Sell | 66,361 | $16.78 | $1,113,205.78 | -23.0% | |
| Jun 19, 2017 | Kirson Eilon D. | Chief Science Officer | Sell | 15,000 | $15.06 | $225,885.00 | -4.9% | |
| Jun 19, 2017 | Danziger Asaf61 | Chief Executive Officer | Sell | 124,720 | $15.51 | $1,934,906.08 | -12.2% | |
| Jun 16, 2017 | Danziger Asaf61 | Chief Executive Officer | Sell | 42,457 | $15.15 | $643,237.63 | -2.0% | |
| Jun 14, 2017 | Danziger Asaf61 | Chief Executive Officer | Sell | 94,102 | $15.22 | $1,432,146.21 | -4.2% | |
| Jun 13, 2017 | Kirson Eilon D. | Chief Science Officer | Sell | 9,044 | $15.01 | $135,768.53 | -2.9% | |
| Jun 12, 2017 | Kirson Eilon D. | Chief Science Officer | Sell | 20,956 | $15.03 | $315,053.39 | -3.2% | |
| Jun 12, 2017 | Danziger Asaf61 | Chief Executive Officer | Sell | 180,601 | $15.13 | $2,731,912.63 | -7.2% | |
| Jun 5, 2017 | Palti Yoram | Chief Technology Officer | Sell | 3,825 | $13.82 | $52,842.38 | -100% |